News & Updates
Filter by Specialty:
Does diabetes worsen survival in metastatic breast cancer?
Diabetes does not appear to increase mortality in patients with metastatic breast cancer (MBC), but diabetes and hyperglycaemia both contribute to worse overall survival (OS) in a cohort of longer-term survivors, a study has found.
Does diabetes worsen survival in metastatic breast cancer?
19 Sep 2022
Poststroke statin treatment confers survival benefits for cancer patients
Statin treatment following ischaemic stroke appears to extend its benefits to improved survival in patients who also have had cancer, a study has found.
Poststroke statin treatment confers survival benefits for cancer patients
16 Sep 2022
Proximal gastrectomy OK for proximal advanced gastric cancer
For patients with proximal advanced gastric cancer (AGC), proximal gastrectomy (PG) appears to be a reasonable treatment option, particularly for those with small tumours, a recent study has found.
Proximal gastrectomy OK for proximal advanced gastric cancer
16 Sep 2022
Maximal androgen blockade the prime prostate cancer treatment option in older patients
Among prostate cancer patients aged ≥75 years, maximal androgen blockage (MAB) appears to be the most common treatment option, reports a new South Korea study. Meanwhile, the combination of leuprolide and bicalutamide is the most common MAB regimen.
Maximal androgen blockade the prime prostate cancer treatment option in older patients
16 Sep 2022
First-line rucaparib boosts PFS in ovarian cancer regardless of HRD status
First-line rucaparib maintenance therapy extends progression-free survival (PFS) in patients with ovarian, fallopian tube, or primary peritoneal cancer, according to results of the phase III ATHENA-MONO trial presented at the ESMO Gynaecological Cancers Conference 2022.